Mindset Pharma Stock Current Valuation
| MSSTFDelisted Stock | USD 0.36 0.00 0.00% |
Valuation analysis of Mindset Pharma helps investors to measure Mindset Pharma's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Mindset Pharma's price fluctuation is very steady at this time. Calculation of the real value of Mindset Pharma is based on 3 months time horizon. Increasing Mindset Pharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Mindset otc stock is determined by what a typical buyer is willing to pay for full or partial control of Mindset Pharma. Since Mindset Pharma is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Mindset OTC Stock. However, Mindset Pharma's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.36 | Real 0.28 | Hype 0.36 |
The real value of Mindset OTC Stock, also known as its intrinsic value, is the underlying worth of Mindset Pharma OTC Stock, which is reflected in its stock price. It is based on Mindset Pharma's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Mindset Pharma's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Mindset Pharma helps investors to forecast how Mindset otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Mindset Pharma more accurately as focusing exclusively on Mindset Pharma's fundamentals will not take into account other important factors: Mindset Pharma OTC Stock Current Valuation Analysis
Mindset Pharma's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Mindset Pharma Current Valuation | 19.22 M |
Most of Mindset Pharma's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Mindset Pharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Mindset Pharma has a Current Valuation of 19.22 M. This is 99.87% lower than that of the Healthcare sector and 99.59% lower than that of the Biotechnology industry. The current valuation for all United States stocks is 99.88% higher than that of the company.
Mindset Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Mindset Pharma's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Mindset Pharma could also be used in its relative valuation, which is a method of valuing Mindset Pharma by comparing valuation metrics of similar companies.Mindset Pharma is currently under evaluation in current valuation category among its peers.
Mindset Fundamentals
| Return On Equity | -2.43 | |||
| Return On Asset | -0.48 | |||
| Profit Margin | (1.64) % | |||
| Operating Margin | (1.33) % | |||
| Current Valuation | 19.22 M | |||
| Shares Outstanding | 95.25 M | |||
| Shares Owned By Insiders | 9.00 % | |||
| Shares Owned By Institutions | 0.88 % | |||
| Price To Book | 28.87 X | |||
| Price To Sales | 4.83 X | |||
| Revenue | 3.91 M | |||
| Gross Profit | 3.91 M | |||
| EBITDA | (16.53 M) | |||
| Net Income | (16.61 M) | |||
| Cash And Equivalents | 8.71 M | |||
| Cash Per Share | 0.09 X | |||
| Total Debt | 171.79 K | |||
| Debt To Equity | 0.12 % | |||
| Current Ratio | 1.18 X | |||
| Book Value Per Share | 0.01 X | |||
| Cash Flow From Operations | 385.56 K | |||
| Earnings Per Share | (0.19) X | |||
| Target Price | 5.02 | |||
| Beta | -0.28 | |||
| Market Capitalization | 20.95 M | |||
| Total Asset | 9.77 M | |||
| Z Score | 69.3 | |||
| Net Asset | 9.77 M |
About Mindset Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Mindset Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Mindset Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Mindset Pharma based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Consideration for investing in Mindset OTC Stock
If you are still planning to invest in Mindset Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Mindset Pharma's history and understand the potential risks before investing.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |